Emmanuelle Polge

4.6k total citations
64 papers, 2.8k citations indexed

About

Emmanuelle Polge is a scholar working on Hematology, Public Health, Environmental and Occupational Health and Oncology. According to data from OpenAlex, Emmanuelle Polge has authored 64 papers receiving a total of 2.8k indexed citations (citations by other indexed papers that have themselves been cited), including 59 papers in Hematology, 38 papers in Public Health, Environmental and Occupational Health and 7 papers in Oncology. Recurrent topics in Emmanuelle Polge's work include Acute Myeloid Leukemia Research (50 papers), Hematopoietic Stem Cell Transplantation (50 papers) and Acute Lymphoblastic Leukemia research (38 papers). Emmanuelle Polge is often cited by papers focused on Acute Myeloid Leukemia Research (50 papers), Hematopoietic Stem Cell Transplantation (50 papers) and Acute Lymphoblastic Leukemia research (38 papers). Emmanuelle Polge collaborates with scholars based in France, Israel and Germany. Emmanuelle Polge's co-authors include Myriam Labopin, Arnon Nagler, Mohamad Mohty, Vanderson Rocha, Jürgen Finke, Norbert Claude Gorin, Christoph Schmid, Gerhard Ehninger, Liisa Volin and Francesco Frassoni and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Journal of Molecular Biology.

In The Last Decade

Emmanuelle Polge

60 papers receiving 2.8k citations

Peers

Emmanuelle Polge
Comparison fields: 5 of 81
  • Hematology 2.3k
  • Public Health, Environmental and Occupational Health 935
  • Oncology 698
  • Immunology 617
  • Molecular Biology 306
Replace Johanna Tischer with:
Johanna Tischer Germany
D I Marks United Kingdom
Yener Koç Türkiye
Ira Braunschweig United States
Nadežda Basara Germany
Masatsugu Tanaka Japan
Alida Dominietto Italy
Th. Büchner Germany
Edward Kanfer United Kingdom
Roberto Crocchiolo Italy
Johanna Tischer Germany View profile →
Citations per field, relative to Emmanuelle Polge
Emmanuelle Polge · 1×
Citations per year, relative to Emmanuelle Polge
Emmanuelle Polge · 1×

Countries citing papers authored by Emmanuelle Polge

Since Specialization
Citations

This map shows the geographic impact of Emmanuelle Polge's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Emmanuelle Polge with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Emmanuelle Polge more than expected).

Fields of papers citing papers by Emmanuelle Polge

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Emmanuelle Polge. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Emmanuelle Polge. The network helps show where Emmanuelle Polge may publish in the future.

Co-authorship network of co-authors of Emmanuelle Polge

This figure shows the co-authorship network connecting the top 25 collaborators of Emmanuelle Polge. A scholar is included among the top collaborators of Emmanuelle Polge based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Emmanuelle Polge. Emmanuelle Polge is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
# Work Indexed citations
1
Older matched sibling donor vs young haploidentical donor for older patients with acute myeloid leukemia
2025 ·Blood Advances ·Xavier Poiré, Myriam Labopin, Emmanuelle Polge, Didier Blaise, Patrice Chevallier, Johan Maertens, Nicolaus Kröger, Caroline Besley, Stéphanie Nguyen, Cristina Castilla‐Llorente, Gèrard Socié, Édouard Forcade, Anne Huynh, Igor Wolfgang Blau, Arnon Nagler, Jaime Sanz, Simona Piemontese, Mohamad Mohty, Fabio Ciceri
2
2
Allogeneic hematopoietic cell transplantation for acute myeloid leukemia with hyperdiploid complex karyotype
2023 ·Bone Marrow Transplantation ·Xavier Poiré, Myriam Labopin, Emmanuelle Polge, Arnold Ganser, Gèrard Socié, Tobias Gedde‐Dahl, Édouard Forcade, Jürgen Finke, Yves Chalandon, Claude‐Eric Bulabois, Ibrahim Yakoub‐Agha, Mahmoud Aljurf, Nicolaus Kröger, Igor Wolfgang Blau, Arnon Nagler, Jordi Esteve, Mohamad Mohty
1
3
Autologous stem cell transplantation in adult patients with intermediate-risk acute myeloid leukemia in first complete remission and no detectable minimal residual disease. A comparative retrospective study with haploidentical transplants of the global committee and the ALWP of the EBMT
2023 ·Bone Marrow Transplantation ·(unknown), Myriam Labopin, Thomas Pabst, Xi Zhang, Erlie Jiang, Alessandra Tucci, Jan J. Cornelissen, Ellen Meijer, (unknown), Emmanuelle Polge, Depei Wu, Mohamad Mohty, Norbert Claude Gorin
4
4
Impact of donor kinship on non-T-cell depleted haploidentical stem cell transplantation with post transplantation cyclophosphamide for acute leukemia: From the ALWP of the EBMT
2022 ·Bone Marrow Transplantation ·Ivetta Danylesko, Christophe Peczynski, Myriam Labopin, Emmanuelle Polge, Johanna Tischer, Didier Blaise, Yener Koç, Zafer Gülbaş, Fabio Ciceri, Mutlu Arat, Luca Castagna, Benedetto Bruno, Anna Maria Raiola, (unknown), Bipin N. Savani, Simona Piemontese, Annalisa Ruggeri, Arnon Nagler, Mohamad Mohty
2
5
Measurable residual disease status and outcome of transplant in acute myeloid leukemia in second complete remission: a study by the acute leukemia working party of the EBMT
2021 ·Blood Cancer Journal ·Maria Gilleece, Avichai Shimoni, Myriam Labopin, Stephen Robinson, Dietrich W. Beelen, Gèrard Socié, Ali Ünal, Arnold Ganser, Antonı́n Vı́tek, Henrik Sengeloev, Ibrahim Yakoub‐Agha, Eleni Tholouli, Emmanuelle Polge, Mohamad Mohty, Arnon Nagler
18
6
Allogeneic stem cell transplantation in AML with t(6;9)(p23;q34);DEK‐NUP214 shows a favourable outcome when performed in first complete remission
2020 ·British Journal of Haematology ·Marina Díaz‐Beyá, Myriam Labopin, Johan Maertens, (unknown), Jakob Passweg, Dietrich W. Beelen, Harry C. Schouten, Gérard Socié, Nicolaas Schaap, Rainer Schwerdtfeger, Liisa Volin, Mauricette Michallet, Emmanuelle Polge, Jorge Sierra, Mohamad Mohty, Jordi Esteve, Arnon Nagler, (unknown)
14
7
Comparison of reduced-intensity conditioning regimens in patients with acute lymphoblastic leukemia >45 years undergoing allogeneic stem cell transplantation—a retrospective study by the Acute Leukemia Working Party of EBMT
2020 ·Bone Marrow Transplantation ·Zinaida Perić, Myriam Labopin, Christophe Peczynski, Emmanuelle Polge, Jan J. Cornelissen, Ben Carpenter, Mike Potter, Ram Malladi, Jenny Byrne, Harry C. Schouten, Nathalie Fegueux, Gèrard Socié, Montserrat Rovira, Jürgen Kuball, Maria Gilleece, Sebastian Giebel, Arnon Nagler, Mohamad Mohty
13
8
Allogeneic haemopoietic transplantation for acute myeloid leukaemia in second complete remission: a registry report by the Acute Leukaemia Working Party of the EBMT
2019 ·Leukemia ·Maria Gilleece, Myriam Labopin, Bipin N. Savani, Ibrahim Yakoub‐Agha, Gèrard Socié, Tobias Gedde‐Dahl, Didier Blaise, Jenny Byrne, Charles Craddock, Jan J. Cornelissen, William Arcese, Édouard Forcade, Charles Crawley, Emmanuelle Polge, Mohamad Mohty, Arnon Nagler
24
9
A haploidentical may be a better choice than a female genoidentical donor to transplant a patient with high risk acute myelogenous leukemia in first remission
2019 ·Bone Marrow Transplantation ·Norbert Claude Gorin, Myriam Labopin, Didier Blaise, Goda Choi, Gèrard Socié, Jean Henri Bourhis, Fabio Ciceri, Emmanuelle Polge, Arnon Nagler, Mohamad Mohty
1
10
Autologous stem cell transplantation in refractory Crohn’s disease – low intensity therapy evaluation (ASTIClite): study protocols for a multicentre, randomised controlled trial and observational follow up study
2019 ·BMC Gastroenterology ·(unknown), John A. Snowden, (unknown), C J Hawkey, Daniel Hind, (unknown), Katie Mellor, Richard Emsley, Laura Mandefield, Ellen Lee, Manuela Badoglio, Emmanuelle Polge, Myriam Labopin, John G. Gribben, A. Graham Pockley, Gemma A. Foulds, Alan Lobo, Simon Travis, Miles Parkes, Jack Satsangi, Diana Papaioannou, James O. Lindsay
20
11
Frequency of lethal central nervous system neurotoxicity in patients undergoing allogeneic stem cell transplantation: a retrospective registry analysis
2019 ·Bone Marrow Transplantation ·(unknown), Christian Schultze‐Florey, Christophe Peczynski, (unknown), Emmanuelle Polge, Gèrard Socié, Didier Blaise, Dietrich W. Beelen, (unknown), Nicolaus Kröger, Matthias Stelljes, Boris V. Afanasyev, Victoria Potter, Armin Gerbitz, Johannes Schetelig, Zinaida Perić, Hélène Schoemans, Christian Koenecke, Grzegorz Basak
1
12
Hematopoietic stem cell transplantation for adult patients with isolated NPM1 mutated acute myeloid leukemia in first remission
2018 ·American Journal of Hematology ·Xavier Poiré, Myriam Labopin, Emmanuelle Polge, Didier Blaise, Patrice Chevallier, Johan Maertens, Éric Deconinck, Édouard Forcade, Alessandro Rambaldi, Gabriela M. Baerlocher, Tsila Zuckerman, Liisa Volin, Harry C. Schouten, Norbert Ifrah, Mohamad Mohty, Jordi Esteve, Arnon Nagler
13
13
Single-Dose Daily Fractionation Is Not Inferior to Twice-a-Day Fractionated Total-Body Irradiation Before Allogeneic Stem Cell Transplantation for Acute Leukemia: A Useful Practice Simplification Resulting From the SARASIN Study
2018 ·International Journal of Radiation Oncology*Biology*Physics ·Yazid Belkacémi, Myriam Labopin, Sebastian Giebel, Gokoulakrichenane Loganadane, Leszek Miszczyk, Mauricette Michallet, Gèrard Socié, Nicolaas Schaap, Jan J. Cornelissen, Ibrahim Yakoub‐Agha, Emmanuelle Polge, Mohamad Mohty, Norbert Claude Gorin, Arnon Nagler
14
14
Reduced Relapse Incidence with FLAMSA–RIC Compared with Busulfan/Fludarabine for Acute Myelogenous Leukemia Patients in First or Second Complete Remission: A Study from the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation
2018 ·Biology of Blood and Marrow Transplantation ·Thomas Heinicke, Myriam Labopin, Christoph Schmid, Emmanuelle Polge, (unknown), Didier Blaise, Ghulam J. Mufti, Anne Huynh, Arne Brecht, Marie‐Pierre Ledoux, J Cahn, Nöel Milpied, Christof Scheid, Yosr Hicheri, Mohamad Mohty, Bipin N. Savani, Arnon Nagler
11
15
The effect of NIMA matching in adult unrelated mismatched hematopoietic stem cell transplantation – a joint study of the Acute Leukemia Working Party of the EBMT and the CIBMTR
2018 ·Bone Marrow Transplantation ·Julia Pingel, Tao Wang, (unknown), (unknown), Arnon Nagler, Michael Haagenson, Katharina Fleischhauer, Katharine C. Hsu, Michael R. Verneris, Stephanie J. Lee, Mohamad Mohty, Emmanuelle Polge, Stephen R. Spellman, Alexander H. Schmidt, Jon J. van Rood
3
16
Allogeneic stem cell transplantation benefits for patients ≥ 60 years with acute myeloid leukemia and FLT3 internal tandem duplication: a study from the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation
2017 ·Haematologica ·Xavier Poiré, Myriam Labopin, Emmanuelle Polge, Jakob Passweg, Charles Craddock, Didier Blaise, Jan J. Cornelissen, Liisa Volin, Nigel H. Russell, Gérard Socié, Mauricette Michallet, Nathalie Fegueux, Patrice Chevallier, Arne Brecht, Mathilde Hunault, Mohamad Mohty, Jordi Esteve, Arnon Nagler
14
17
Prediction of Allogeneic Hematopoietic Stem-Cell Transplantation Mortality 100 Days After Transplantation Using a Machine Learning Algorithm: A European Group for Blood and Marrow Transplantation Acute Leukemia Working Party Retrospective Data Mining Study
2015 ·Journal of Clinical Oncology ·Roni Shouval, Myriam Labopin, (unknown), (unknown), Avichai Shimoni, Fabio Ciceri, Jordi Esteve, Sebastian Giebel, Norbert Claude Gorin, Christoph Schmid, Emmanuelle Polge, Mahmoud Aljurf, Nicolaus Kröger, Charles Craddock, Andrea Bacigalupo, Jan J. Cornelissen, Frédéric Baron, Ron Unger, Arnon Nagler, Mohamad Mohty
105
18
A prospective registration study to determine feasibility of hematopoietic SCT in adults with acute leukemia: planning, expectations and reality
2013 ·Bone Marrow Transplantation ·Myriam Labopin, (unknown), Emmanuelle Polge, G. Socié, Günhan Gürman, Éliane Gluckman, Pavel Jindra, Xavier Poiré, (unknown), Tapani Ruutu, Giuseppe Milone, William Arcese, Mohamad Mohty, Vanderson Rocha, (unknown)
7
19
Donor Lymphocyte Infusion in the Treatment of First Hematological Relapse After Allogeneic Stem-Cell Transplantation in Adults With Acute Myeloid Leukemia: A Retrospective Risk Factors Analysis and Comparison With Other Strategies by the EBMT Acute Leukemia Working Party
2007 ·Journal of Clinical Oncology ·Christoph Schmid, Myriam Labopin, Arnon Nagler, Martin Bornhäuser, Jürgen Finke, Athanasios Fassas, Liisa Volin, Günhan Gürman, Johan Maertens, Pierre Bordigoni, Ernst Holler, Gerhard Ehninger, Emmanuelle Polge, Norbert Claude Gorin, (unknown), Vanderson Rocha
360
20
Risk assessment in adult acute lymphoblastic leukaemia before early haemopoietic stem cell transplantation with a geno-identical donor: an easy clinical prognostic score to identify patients who benefit most from allogeneic haemopoietic stem cell transplantation
2003 ·Leukemia ·NC Gorin, Myriam Labopin, Emmanuelle Polge, Catherine Cordonnier, J. P. Jouet, Mauricette Michallet, Didier Blaise, Josy Reiffers, Bernard Rio, Nöel Milpied, Francesco Frassoni, (unknown)
14

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Johanna Tischer Breakdown of academic impact, for papers by D I Marks Breakdown of academic impact, for papers by Yener Koç Breakdown of academic impact, for papers by Ira Braunschweig Breakdown of academic impact, for papers by Nadežda Basara Breakdown of academic impact, for papers by Masatsugu Tanaka Breakdown of academic impact, for papers by Alida Dominietto Breakdown of academic impact, for papers by Th. Büchner Breakdown of academic impact, for papers by Edward Kanfer Breakdown of academic impact, for papers by Roberto Crocchiolo
Rankless by CCL
2026